„Cervical cancer screening from home: Insights from a MedTech start-up founder“ – Biotech Entrepreneurship and Leadership Lectures with Michaela Fesenfeld
We are pleased to announce the next „Biotech Entrepreneurship and Leadership Lecture„. Michaela Fesenfeld, CEO and co-founder of Novoscreen, will speak about Cervical cancer screening from home: Insights from a MedTech start-up founder.
Michaela is one of 2 founding members developing an innovative medical device for cervical cancer prevention. At Novoscreen she is in charge of business development, business plan creation, marketing strategy, clinical trial, acquisition of funding and strategic partners. The startup has been awarded as winner of the German Science4Life business model competition (phase 2).
While building the startup Novoscreen, Michaela is still employed at Merck as brand manager for endocrinology. At Merck, she is in charge of overall brand strategy and communication creating promotion materials and congress booth.
When: Wednesday, September 12, 2018, 5:00-06:30 p.m.
Where: Marsilius Arkaden of Heidelberg University, Seminar Room 1, Im Neuenheimer Feld 130.1, Heidelberg
A registration for the lectures is not required.